Idera Pharmaceuticals Inc. | Key People and Executives
Vincent J. Milano
President, Chief Executive Officer & Director
James A. Geraghty
Chairman
William S. Reardon
Independent Director
Maxine Gowen
Independent Director
Kelvin M. Neu
Independent Director
Julian Charles Baker
Independent Director
Mark Alan Goldberg
Independent Director
Vincent J. Milano
President, Chief Executive Officer & Director
Louis J. Arcudi
CFO, Treasurer & Chief Accounting Officer
Jonathan Yingling
Chief Scientific Officer & Senior Vice President
Joanna C. Horobin
Chief Medical Officer & Senior Vice President
Shah Rahimian
Medical Director
Robert Clayton Fletcher
SVP-Business Development & Strategic Planning
Robert A. Doody
VP-Investor Relations & Corporate Communications
Jill Conwell
Vice President-Human Resources
James A. Geraghty
Chairman
William S. Reardon
Independent Director
Maxine Gowen
Independent Director
Kelvin M. Neu
Independent Director
Julian Charles Baker
Independent Director
Mark Alan Goldberg
Independent Director
| Address |
505 Eagleview Boulevard
Exton Pennsylvania 19341
United States
|
|
Employees
|
- |
| Website |
http://www.iderapharma.com |
| Updated |
07/08/2019 |
| Idera Pharmaceuticals, Inc. is a clinical stage biotechnology company, which focuses on the discovery, development and commercialization of novel oligonucleotide therapeutics for oncology and rare diseases. The firm uses two distinct proprietary drug discovery technology platforms to design and develop drug candidates: Toll-like receptor targeting technology and third-generation antisense technology. The company was founded by Paul C. |
